Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 201 - 220 of 447 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101]
Ariyan, Charlotte
  • Melanoma
A Phase II Study of Ipilimumab versus Standard Chemotherapy after Initial Therapy in Patients with Inoperable or Advanced Gastric or Gastroesophageal Cancer
[Protocol 12-277]
Ku, Geoffrey
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204]
Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of KW-0761 or Standard Therapy in Patients with Previously Treated Adult T-Cell Leukemia-Lymphoma
[Protocol 12-251]
Horwitz, Steven
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of Maribavir to Treat Resistant Cytomegalovirus Infection in Transplant Recipients
[Protocol 12-281]
Papanicolaou, Genovefa
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
A Phase II Study of mFOLFOX6 with Bevacizumab or Tivozanib in Patients with Metastatic Colorectal Cancer
[Protocol 12-066]
Cercek, Andrea
  • Colorectal Cancer
    • Colon Cancer
A Phase II Study of MK-2206 in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
[Protocol 11-193]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of MK-2206 in Patients with Recurrent or Advanced Endometrial Cancer Stratified by PIK3CA Mutation Status
[Protocol 11-071]
Makker, Vicky
  • Endometrial and other Uterine Cancers
    • Endometrial Cancer
A Phase II Study of MLN8237 (Alisertib) with Paclitaxel versus Paclitaxel Alone in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-100]
Tew, William
  • Ovarian Cancer
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of MLN8237 in Patients with Advanced Prostate Cancer
[Protocol 13-042]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164]
Hyman, David
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of MLN8237 in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
[Protocol 12-096]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106]
Chaft, Jamie
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026]
Kobos, Rachel
  • Kidney Cancer
  • Sarcomas
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142]
Dang, Chau
  • Breast Cancer
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077]
Goldberg, Jenna
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma